Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Electroconvulsive Therapy01:30

Electroconvulsive Therapy

83
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
83

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association of Cerebrospinal Fluid-Restricted Oligoclonal Bands With Relapsing Pediatric Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.

Pediatric neurology·2026
Same author

The gut microbiome in pediatric-onset acquired demyelinating syndromes by myelin oligodendrocyte glycoprotein antibody status.

Multiple sclerosis and related disorders·2026
Same author

Factors Influencing Early and Late B-Cell Repopulation After Rituximab Therapy in Pediatric Central Nervous System Inflammatory Disorders.

Pediatric neurology·2026
Same author

Higher ultra-processed food consumption is associated with higher likelihood of paediatric-onset multiple sclerosis.

Multiple sclerosis and related disorders·2026
Same author

The Use of Patient-Reported Outcome Measures in Developmental Age: A Complementary Tool for Pediatric Multiple Sclerosis Prognosis.

Neurology and therapy·2026
Same author

Characteristic patterns of complement deposition in NMOSD, MOGAD, and MS.

Acta neuropathologica·2026

Related Experiment Video

Updated: Jul 28, 2025

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice
05:44

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice

Published on: October 13, 2023

1.5K

Pediatric multiple sclerosis: The 2022 ECTRIMS lecture.

Brenda Banwell1

  • 1Brenda BanwellChildren's Hospital of Philadelphia, Grace E. Loeb Chair in Neuroscience, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Multiple Sclerosis (Houndmills, Basingstoke, England)
|May 30, 2023
PubMed
Summary
This summary is machine-generated.

Prompt recognition and treatment of pediatric-onset multiple sclerosis (POMS) are crucial. Research suggests MS is a single disease across ages, offering unique insights from studying young patients.

Keywords:
ECTRIMSPediatricmultiple sclerosis

More Related Videos

Author Spotlight: Repetitive Transcranial Magnetic Stimulation Combined with Movement Observation in Cerebral Palsy
07:20

Author Spotlight: Repetitive Transcranial Magnetic Stimulation Combined with Movement Observation in Cerebral Palsy

Published on: August 9, 2024

1.2K
The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

58.1K

Related Experiment Videos

Last Updated: Jul 28, 2025

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice
05:44

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice

Published on: October 13, 2023

1.5K
Author Spotlight: Repetitive Transcranial Magnetic Stimulation Combined with Movement Observation in Cerebral Palsy
07:20

Author Spotlight: Repetitive Transcranial Magnetic Stimulation Combined with Movement Observation in Cerebral Palsy

Published on: August 9, 2024

1.2K
The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

58.1K

Area of Science:

  • Neurology
  • Immunology
  • Pediatrics

Background:

  • Multiple sclerosis (MS) diagnosis in children and youth (pediatric-onset MS or POMS) is increasingly recognized.
  • The inclusion of pediatric patients in diagnostic criteria has advanced POMS identification.
  • Research indicates MS is a single disease entity across all age groups.

Purpose of the Study:

  • To highlight the significance of early POMS recognition and treatment.
  • To discuss the unique insights gained from studying POMS pathobiology.
  • To outline the evolving landscape of pediatric MS clinical trials and research.

Main Methods:

  • Review of current research on POMS epidemiology, genetics, and immunology.
  • Discussion of emerging pediatric clinical trial designs and regulatory considerations.
  • Emphasis on international collaborative efforts and POMS research priorities.

Main Results:

  • MS pathobiology may be better understood through studying younger patients.
  • Pediatric trials for MS therapies are developing, requiring specific designs and safety focus.
  • International collaboration is essential due to the rarity of POMS.

Conclusions:

  • Early diagnosis and treatment are vital for POMS.
  • Further research and international collaboration are needed to advance POMS care and treatment options.
  • Long-term safety and efficacy data are critical for pediatric MS therapies.